FTIOP
BMY icon

Fiduciary Trust International of Pennsylvania’s Bristol-Myers Squibb BMY Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$13.5M Buy
241,451
+43,607
+22% +$2.67M 0.63% 49
2019
Q4 		$12.7M Buy
197,844
+55,583
+39% +$3.18M 0.47% 59
2019
Q3 		$7.21M Sell
142,261
-1,055
-0.7% -$49.6K 0.29% 95
2019
Q2 		$6.5M Sell
143,316
-3,262
-2% -$152K 0.27% 101
2019
Q1 		$6.99M Buy
146,578
+8,340
+6% +$415K 0.3% 79
2018
Q4 		$7.19M Sell
138,238
-20,849
-13% -$1.12M 0.36% 74
2018
Q3 		$9.88M Sell
159,087
-1,573
-1% -$93.3K 0.41% 60
2018
Q2 		$8.89M Sell
160,660
-4,265
-3% -$230K 0.4% 68
2018
Q1 		$10.4M Sell
164,925
-1,382
-0.8% -$88.9K 0.49% 62
2017
Q4 		$10.2M Buy
166,307
+1,420
+0.9% +$88.8K 0.46% 71
2017
Q3 		$10.5M Sell
164,887
-2,557
-2% -$149K 0.51% 61
2017
Q2 		$9.33M Buy
167,444
+32,649
+24% +$1.78M 0.46% 70
2017
Q1 		$7.33M Buy
134,795
+1,900
+1% +$104K 0.55% 54
2016
Q4 		$7.77M Buy
132,895
+2,625
+2% +$144K 0.62% 51
2016
Q3 		$7.02M Sell
130,270
-99,782
-43% -$6.41M 0.57% 53
2016
Q2 		$16.9M Buy
230,052
+49,320
+27% +$3.48M 1.37% 18
2016
Q1 		$11.5M Buy
180,732
+57,055
+46% +$3.6M 0.98% 31
2015
Q4 		$8.51M Buy
123,677
+24
+0% +$1.59K 0.73% 47
2015
Q3 		$7.32M Sell
123,653
-34,264
-22% -$2.17M 0.68% 52
2015
Q2 		$10.5M Buy
157,917
+13,697
+9% +$903K 0.62% 52
2015
Q1 		$9.3M Buy
144,220
+156
+0.1% +$9.77K 0.6% 56
2014
Q4 		$8.5M Buy
144,064
+9,138
+7% +$515K 0.56% 52
2014
Q3 		$6.91M Buy
134,926
+2,333
+2% +$117K 0.47% 63
2014
Q2 		$6.43M Sell
132,593
-2,970
-2% -$146K 0.44% 65
2014
Q1 		$7.04M Sell
135,563
-3,284
-2% -$175K 0.51% 60
2013
Q4 		$7.38M Sell
138,847
-1,050
-0.8% -$53.5K 0.55% 58
2013
Q3 		$6.47M Sell
139,897
-1,590
-1% -$69.8K 0.53% 59
2013
Q2 		$6.32M Buy
+141,487
New +$6.14M 0.56% 55

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's BMY Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania increased its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2020, buying an estimated $2.67M and bringing the position to 241,451 shares worth $13.5M. The position accounts for 0.63% of the portfolio, ranked #49.

Fiduciary Trust International of Pennsylvania first reported a position in BMY in Q2 2013 and has held it in 28 quarters since. The position peaked at $16.9M in Q2 2016. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Fiduciary Trust International of Pennsylvania held 241,451 shares of Bristol-Myers Squibb worth $13.5M as of Q1 2020.
  • Fiduciary Trust International of Pennsylvania bought 43,607 Bristol-Myers Squibb shares in Q1 2020, an estimated $2.67M.
  • Bristol-Myers Squibb made up 0.63% of Fiduciary Trust International of Pennsylvania's portfolio in Q1 2020, its #49 holding.
  • Fiduciary Trust International of Pennsylvania first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 28 quarters since.
  • Fiduciary Trust International of Pennsylvania's Bristol-Myers Squibb position peaked at $16.9M in Q2 2016.
  • 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.